Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PHB1 pseudogene 4 (PHB1P4) is classified as a pseudogene, meaning it is a DNA sequence similar to a protein-coding gene but generally considered non-functional due to loss of coding potential, lack of protein expression, or disabling mutations[5]. There is no evidence that PHB1P4 encodes a functional protein, nor that it acts as a therapeutic target (such as a receptor, enzyme, transporter, etc.). No references describe PHB1P4 having a biological function, involvement in disease, or interaction with drugs. Its annotation is as a pseudogene related to the prohibitin 1 (PHB1) gene, which itself is functionally significant in cell proliferation, apoptosis, and cancer, but PHB1P4 does not share these attributes[5]. There is no evidence that PHB1P4 serves as a biomarker or has associated safety concerns. Any references to "prohibitin pseudogene" functions in disease primarily refer to other pseudogenes, such as PHBP1[4], but not PHB1P4. Note: PHB1P4 should not be confused with the protein-coding PHB1 gene, which has established roles in cell biology and disease. PHB1P4 is not considered a biologically or pharmacologically relevant target[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PHB1 pseudogene 4 (PHB1P4).